on 09 Apr 2024
Last Applicant/ Owned by
Alt-echenheim 34
rankfurt
E
60386
Serial Number
97839309 filed on 14th Mar 2023
Registration Number
7352095 registered on 09th Apr 2024
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
scientific analysis services for the identification and physical characterization of chemical molecules; scientific and technical services, namely, scientific analysis of industrial installations; scientific and technological services, namely, applied scientific research and development services, namely, conception of development or commercial batches for third parties in the fields of pharmaceutiRead More
nucleic acid analysis for medical diagnostic and treatment purposes; oligonucleotide analysis for medical diagnostic and treatment purposes
30th Apr 2017
30th Apr 2017
scientific analysis services for the identification and physical characterization of chemical molecules; scientific and technical services, namely, scientific analysis of industrial installations; scientific and technological services, namely, applied scientific research and development services, namely, conception of development or commercial batches for third parties in the fields of pharmaceuticals and chemicals; scientific and technological services, namely, consulting and assistance in the research and development of chemicals and pharmaceuticals, including experimental and production processes and installations; scientific and technological services, namely, consulting and assistance in the research and development of pharmaceuticals; scientific development services in the field of biochemistry; scientific laboratory services; scientific research and development services for chemicals for the products of third parties, namely, the scientific and technical development of synthetic processes in the field of chemistry and biochemistry; scientific research and development services in the field of pharmaceuticals; scientific research and scientific and technical development in the field of pharmaceutical, chemical, agrochemical and industrial processes; scientific research services, namely, nucleic acid analysis; scientific research services, namely, oligonucleotide analysis; scientific services, namely, scientific analysis allowing the identification and physical characterization of chemical molecules; scientific services, namely, scientific research and industrial analysis in the field of pharmaceuticals, chemicals, and agrochemical and industrial processes; scientific study and research in the area of industrial quality; development of methods of analysis for chemical and pharmaceutical products and bio-organics; scientific study and research services in the field of industrial safety
30th Apr 2017
30th Apr 2017
biochemical contract manufacturing services; chemical synthesis services, namely, custom synthesis of chemicals for others; custom manufacture of biopharmaceuticals; custom manufacture of pharmaceuticals; custom manufacturing of oligonucleotides; custom modification of antibody; custom modification of protein; development services, namely, design and development of manufacturing processes for others in the field of oligonucleotides; manufacturing, namely, contract manufacturing in the field of oligonucleotides; processing of biopharmaceutical materials for others; processing of chemical reagents; processing of chemicals; processing of medicinal materials; processing of oligonucleotides; processing of peptides; processing of proteins; technical and scientific services, namely, providing technical information in the field of pharmaceutical manufacturing
30th Apr 2017
30th Apr 2017
nucleic acid reagents, agents, preparations and substances for medical purposes; nucleic acid sequences for medical and veterinary use; oligonucleotides for diagnostic purposes; oligonucleotides for medical diagnostic purposes; oligonucleotides for medical use; oligonucleotides for pharmaceutical purposes; pharmaceutical preparations against genetic diseases; pharmaceutical preparations against metabolic diseases; pharmaceutical preparations against neurological diseases; pharmaceutical preparations for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, respiratory diseases, cancer, allergies, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, eye disease, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; pharmaceutical preparations for wound healing; reagents for medical purposes; reagents for medical use; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing; tumor suppressing agents
30th Apr 2017
30th Apr 2017
oligonucleotides for use in the manufacture of pharmaceuticals; oligopeptides for industrial use; peptide substrates for scientific use; peptides for use in industry and science; peptides for use in research and the manufacture of reagents, diagnostic reagents for science and research use; pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; phosphoproteins; proteins for use in industry and science; reagents for research purposes; reagents for scientific use; nucleic acid for diagnostic research; nucleic acid for diagnostic manufacturing
30th Apr 2017
30th Apr 2017
No 97839309
No Service Mark
No
No
No
No
No
No
No
No
No
26.01.02 -
Plain single line circles
26.01.20 -
Circles within a circle
26.01.29 -
Helixes
Status Date | Action Taken |
---|---|
12th Apr 2024 | TEAS SECTION 7 REQUEST RECEIVE |
09th Apr 2024 | NOTICE O REGISTRATION CONIRMATION EMAILE |
09th Apr 2024 | REGISTERE-PRINCIPAL REGISTER |
23rd Jan 2024 | OICIAL GAZETTE PUBLICATION CONIRMATION E-MAILE |
23rd Jan 2024 | PUBLISHE OR OPPOSITION |
03rd Jan 2024 | NOTIICATION O NOTICE O PUBLICATION E-MAILE |
15th Dec 2023 | NOTICE O ACCEPTANCE O AMENMENT TO ALLEGE USE E-MAILE |
14th Dec 2023 | APPROVE OR PUB - PRINCIPAL REGISTER |
14th Dec 2023 | EXAMINER'S AMENMENT ENTERE |
14th Dec 2023 | NOTIICATION O EXAMINERS AMENMENT E-MAILE |